WuXi Biologics (Cayman) Balance Sheet Health
Financial Health criteria checks 5/6
WuXi Biologics (Cayman) has a total shareholder equity of CN¥44.6B and total debt of CN¥2.2B, which brings its debt-to-equity ratio to 4.8%. Its total assets and total liabilities are CN¥56.1B and CN¥11.5B respectively. WuXi Biologics (Cayman)'s EBIT is CN¥3.5B making its interest coverage ratio -18.3. It has cash and short-term investments of CN¥9.5B.
Key information
4.8%
Debt to equity ratio
CN¥2.16b
Debt
| Interest coverage ratio | -18.3x |
| Cash | CN¥9.53b |
| Equity | CN¥44.64b |
| Total liabilities | CN¥11.46b |
| Total assets | CN¥56.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2269's short term assets (CN¥19.8B) exceed its short term liabilities (CN¥6.8B).
Long Term Liabilities: 2269's short term assets (CN¥19.8B) exceed its long term liabilities (CN¥4.7B).
Debt to Equity History and Analysis
Debt Level: 2269 has more cash than its total debt.
Reducing Debt: 2269's debt to equity ratio has increased from 0% to 4.8% over the past 5 years.
Debt Coverage: 2269's debt is well covered by operating cash flow (149.3%).
Interest Coverage: 2269 earns more interest than it pays, so coverage of interest payments is not a concern.